Global Pharmaceutical Manufacturing Market Overview 2023-2030: Substantial Growth Anticipated Despite Patent Expiry of Leading Profitable Drugs
August 28, 2023 06:28 ET
|
Research and Markets
Dublin, Aug. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Pharmaceutical Manufacturing Market Overview 2023-2030" report has been added to ResearchAndMarkets.com's offering.The global pharmaceutical...
Small Molecule Innovator CDMO Market Investments, Scope, Profit-Sources & Revenue Share Analysis | Latest InsightAce Report
August 14, 2023 12:25 ET
|
InsightAce Analytic Pvt. LTd.
Jersey City, NJ, Aug. 14, 2023 (GLOBE NEWSWIRE) -- The Global Small Molecule Innovator CDMO Market is estimated to reach over USD 76.50 billion by 2031, exhibiting a CAGR of 6.1% during the forecast...
Technology-enabled Drug Discovery Research Report 2023: AI Integration into Drug Discovery Remains on an Upward Trajectory, Increasing Almost 40% as of 2022
August 08, 2023 04:43 ET
|
Research and Markets
Dublin, Aug. 08, 2023 (GLOBE NEWSWIRE) -- The "Growth Indicators for Technology-enabled Drug Discovery" report has been added to ResearchAndMarkets.com's offering. Innovative Business Models...
Provectus Biopharmaceuticals Announces Acceptance of PV-10 Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
August 07, 2023 07:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that preclinical data from ongoing research on investigational cancer immunotherapy PV-10 (rose bengal...
Generic Oncology Drugs Market Surpasses US$24.4 billion in 2022, Set to Grow at CAGR 6.5% through 2033 | Persistence Market Research
August 03, 2023 11:32 ET
|
Persistence Market Research
New York, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The global market for generic oncology drugs is estimated to be worth US$24.4 billion in 2022, with a 6.5% CAGR to reach US$49.9 billion by the end of...
Provectus Biopharmaceuticals Announces Acceptance of PV-10 Poster Presentations at Society for Melanoma Research (SMR) 2023 Congress
August 01, 2023 07:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that data from ongoing clinical trials of investigational cancer immunotherapy PV-10 (rose bengal sodium) for...
Europe Active Pharmaceutical Ingredients Market Set for Robust Growth Driven by Rising Biologics Adoption, Patent Expirations and Outsourcing Trends
July 31, 2023 05:58 ET
|
Research and Markets
Dublin, July 31, 2023 (GLOBE NEWSWIRE) -- The "Europe Active Pharmaceutical Ingredients Market 2022-2032" report has been added to ResearchAndMarkets.com's offering. The report presents an...
Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems Research Report 2023
July 04, 2023 04:28 ET
|
Research and Markets
Dublin, July 04, 2023 (GLOBE NEWSWIRE) -- The "Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems" report has been added to ResearchAndMarkets.com's offering. The scope of...
Provectus Biopharmaceuticals Establishes Research Collaboration with University of Tennessee College of Veterinary Medicine to Investigate Pharmaceutical-Grade Small Molecule Immunotherapy Rose Bengal Sodium for Canine Soft Tissue Sarcomas
June 28, 2023 07:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, June 28, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company has initiated a new sponsored research program with the University of Tennessee College of...
Provectus Biopharmaceuticals Announces Stockholder Approval to Undertake Reverse Split of Outstanding Equities and Reduce Number of Authorized Equities by Same Ratio
June 26, 2023 07:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, June 26, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company’s shareholders have approved the proposals of Provectus’s Board of Directors (Board) to seek...